http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2029121-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate | 2007-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc05f4d90e485aacb41418102753ceb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22a3f0159b51f736c45adfea8cc2e719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ddab0778769035b89d42ca3c0e09df1 |
publicationDate | 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2029121-A1 |
titleOfInvention | Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux |
abstract | The invention relates to a transdermal therapeutic system, preferably as transdermal patch, which has an active ingredient-containing matrix which consists substantially of a water-insoluble base material such as, for example, rubber and synthetic polymers, into which water-soluble and/or water-swellable inclusion bodies, e.g. composed of polyvinyl alcohol or polyethylene glycol, which comprise micronized or nanoscale active ingredient particles are incorporated. |
priorityDate | 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.